Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Ann Neurol. 2015 Jul 28;78(3):466–476. doi: 10.1002/ana.24460

Table 2.

Population Distribution of Long-term Exposure to Fine Particulate Matter in Relation to Selected Clinical Characteristics in the WHIMS-MRI Study Cohort (1999–2006)

Population Characteristics N** Quartile of cumulative average of annual PM2.5 p-value*
5.75–10.67 ug/m3
(N=351)
10.67–12.24 ug/m3
(N=351)
12.24–14.16 ug/m3
(N=351)
14.16–22.18 ug/m3
(N=350)
Hormone treatment ever 0.06
  No 752 181 (24.1%) 201 (26.7%) 171 (22.7%) 199 (26.5%)
  Yes 651 170 (26.1%) 150 (23%) 180 (27.6%) 151 (23.2%)

Hypertension ever 0.23
  No 889 229 (25.8%) 233 (26.2%) 209 (23.5%) 218 (24.5%)
  Yes 505 121 (24%) 115 (22.8%) 140 (27.7%) 129 (25.5%)

Diabetes treated ever (pills or shots)
  No 1356 347 (25.6%) 338 (24.9%) 335 (24.7%) 336 (24.8%)
  Yes 46 4 (8.7%) 12 (26.1%) 16 (34.8%) 14 (30.4%)

High cholesterol requiring pills ever 0.18
  No 1153 302 (26.2%) 284 (24.6%) 280 (24.3%) 287 (24.9%)
  Yes 223 43 (19.3%) 62 (27.8%) 60 (26.9%) 58 (26%)

Cardiovascular disease ever 0.44
  No 1193 302 (25.3%) 307 (25.7%) 294 (24.6%) 290 (24.3%)
  Yes 193 45 (23.3%) 42 (21.8%) 51 (26.4%) 55 (28.5%)

presented as the number (row %) belonging to each exposure quartile, given the indicated subcategory of population characteristics

*

p-value: comparing the distribution of exposure quartile across subcategories of each personal characteristics

**

The total number of subjects summed up across each subcategory varies slightly because of missing values.